Literature DB >> 6256796

delta 9-THC as a discriminative stimulus in rats and pigeons: generalization to THC metabolites and SP-111.

T U Järbe, D E McMillan.   

Abstract

In a drug discrimination paradigm pigeons and rats were trained with an operant procedure to discriminate between the presence and absence of the effects of delta 9-THC (1.0 and 3.0 mg/kg, injected IM 90 min and I.P. 30 min before the start of the session). Once trained, various THC metabolites as well as a water-soluble derivative of THC (SP-111), were substituted for delta 9-THC to test for generalization to the training drug. Generalization to delta 9-THC occurred with the 11-hydroxy metabolites and the potency order was 11-OH-delta 9-THC > 11-OH-delta 8-THC greater than or equal to delta 9-THC. Among the other metabolites tested (8 alpha-OH-delta 9-THC, 8 alpha, 11-di-OH-delta 9-THC, 8 beta-OH-delta 9-THC, 8 beta, 11-di-OH-delta 9-THC), it was only 11-di-OH-delta 9-THC that completely substituted for delta 9-THC in pigeons, albeit at very high dose levels (rats were not tested with these metabolites). SP-111 generalized to delta 9-THC in both species. However, the onset of action of SP-111 was slower than that for delta 9-THC, especially in pigeons. These studies show the importance of obtaining complete dose-effect determinations over time when assessing structure-activity relationships with drug-discrimination procedures.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6256796     DOI: 10.1007/bf00433063

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  16 in total

1.  Discriminative effects of combinations of delta 9-tetrahydrocannabinol and pentobarbital in pigeons.

Authors:  T U Järbe; G C Ohlin
Journal:  Psychopharmacology (Berl)       Date:  1979-06-21       Impact factor: 4.530

2.  A comparison of the pharmacological activity of delta 9-tetrahydrocannabinol and its monohydroxylated metabolites in man.

Authors:  M Perez-Reyes; M C Timmons; M A Lipton; H D Christensen; K H Davis; M E Wall
Journal:  Experientia       Date:  1973-08-15

Review 3.  Structure-activity relationships in man of cannabis constituents, and homologs and metabolites of delta9-tetrahydrocannabinol.

Authors:  L E Hollister
Journal:  Pharmacology       Date:  1974       Impact factor: 2.547

4.  Potential therapeutic applications of naturally occurring and synthetic cannabinoids.

Authors:  H N Bhargava
Journal:  Gen Pharmacol       Date:  1978

5.  Delta9-THC as a discriminative cue in pigeons: effects of delta8-THC, CBD, and CBN.

Authors:  T U Järbe; B G Henriksson; G C Ohlin
Journal:  Arch Int Pharmacodyn Ther       Date:  1977-07

6.  Delta 9-Tetrahydrocannabinol, ethanol, and amphetamine as discriminative stimuli-generalization tests with other drugs.

Authors:  O F Bueno; E A Carlini; E Finkelfarb; J S Suzuki
Journal:  Psychopharmacologia       Date:  1976-04-15

7.  Effects of delta-9-THC and a water soluble ester of delta-9-THC on schedule-controlled behavior.

Authors:  L A Dykstra; D E McMillan; L S Harris
Journal:  Pharmacol Biochem Behav       Date:  1975 Jan-Feb       Impact factor: 3.533

8.  Discriminative response control produced with hashish, tetrahydrocannabinols (delta 8-THC and delta 9-THC), and other drugs.

Authors:  T U Järbe; B G Henriksson
Journal:  Psychopharmacologia       Date:  1974

9.  Water-soluble derivatives of 1 -tetrahydrocannabinol.

Authors:  B A Zitko; J F Howes; R K Razdan; B C Dalzell; H C Dalzell; J C Sheehan; H G Pars; W L Dewey; L S Harris
Journal:  Science       Date:  1972-08-04       Impact factor: 47.728

10.  Characteristics of tetrahydrocannabinol (THC)-produced discrimination in rats.

Authors:  T U Järbe; J O Johansson; B G Henriksson
Journal:  Psychopharmacology (Berl)       Date:  1976-07-28       Impact factor: 4.530

View more
  8 in total

1.  AM2389, a high-affinity, in vivo potent CB1-receptor-selective cannabinergic ligand as evidenced by drug discrimination in rats and hypothermia testing in mice.

Authors:  Torbjörn U C Järbe; Sherrica Tai; Brian J LeMay; Spyros P Nikas; Vidyanand G Shukla; Alexander Zvonok; Alexandros Makriyannis
Journal:  Psychopharmacology (Berl)       Date:  2011-10-12       Impact factor: 4.530

2.  Comparison of the discriminative stimulus and response rate effects of Δ9-tetrahydrocannabinol and synthetic cannabinoids in female and male rats.

Authors:  Jenny L Wiley; Timothy W Lefever; Julie A Marusich; Rebecca M Craft
Journal:  Drug Alcohol Depend       Date:  2017-01-11       Impact factor: 4.492

3.  Generalization of the discriminative stimulus properties of delta 9-THC to delta 9(11)-THC in rats.

Authors:  A Semjonow; M Binder
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

4.  Discriminative stimulus properties of delta9-tetrahydrocannabinol (THC) in C57Bl/6J mice.

Authors:  Robert E Vann; Jonathan A Warner; Kristen Bushell; John W Huffman; Billy R Martin; Jenny L Wiley
Journal:  Eur J Pharmacol       Date:  2009-05-23       Impact factor: 4.432

5.  A repeated test procedure to assess onset and duration of the cue properties of (-) delta 9-THC, (-) delta 8-THC-DMH and (+) delta 8-THC.

Authors:  T U Järbe; M D Swedberg; R Mechoulam
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

6.  Discriminative stimulus and subjective effects of smoked marijuana in humans.

Authors:  L D Chait; S M Evans; K A Grant; J B Kamien; C E Johanson; C R Schuster
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

7.  Hippocampal CB(1) receptors mediate the memory impairing effects of Delta(9)-tetrahydrocannabinol.

Authors:  Laura E Wise; Andrew J Thorpe; Aron H Lichtman
Journal:  Neuropsychopharmacology       Date:  2009-03-25       Impact factor: 7.853

8.  Sex, species and age: Effects of rodent demographics on the pharmacology of ∆9-tetrahydrocanabinol.

Authors:  Jenny L Wiley; Daniel G Barrus; Charlotte E Farquhar; Timothy W Lefever; Thomas F Gamage
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2020-08-15       Impact factor: 5.067

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.